Part,  Chapter, Paragraph

 1   II,     5.  1.  2|             Chronic diseases and their treatments can easily interfere with
 2   II,     5.  2.  2|              disease and impact of the treatments. These data, although collected
 3   II,     5.  2.  2|             disease and impacts of the treatments. As already explained, MONICA
 4   II,     5.  2.  3|               for CVD morbidity. Three treatments are recommended for IHD
 5   II,     5.  2.  5|              survival linked to better treatments. This highlights the importance
 6   II,     5.  2.  5|                monitor disease trends, treatments and risk factors in order
 7   II,     5.  2.  6|              or through more expensive treatments, such as invasive surgery.
 8   II,     5.  2.  6|                invasive and biological treatments contribute substantially
 9   II,     5.  2.  7|              from Modern Cardiological Treatments and Population Risk Factor
10   II,     5.  3.  7|             new innovative cancer drug treatments and the importance of equal
11   II,     5.  4.  5|         patterns in time and different treatments. Certain medical conditions
12   II,     5.  4.  6|          timely initiation of adequate treatments. The WHO 2003 report defines
13   II,     5.  5.Int|      availability of modern, effective treatments. Better policies and provision
14   II,     5.  5.  2|                and access to effective treatments falls into the category
15   II,     5.  5.  2|          access to currently available treatments, efficient health services,
16   II,     5.  5.  3|            number of data, surveys and treatments being available. It becomes
17   II,     5.  5.  3|            diagnosis and the access to treatments are necessary to enable
18   II,     5.  5.  3|                structured psychosocial treatments allow a remarkable fraction
19   II,     5.  5.  3|             treated although effective treatments exist) for schizophrenia
20   II,     5.  5.  3| psychotherapeutic than pharmacological treatments (Lehman et al, 2003). Apart
21   II,     5.  5.  3|           untreated although effective treatments exist), the median treatment
22   II,     5.  5.  3|             provision of psycho-social treatments in routine care, the standard
23   II,     5.  5.  3|                  While pharmacological treatments are extensively studied,
24   II,     5.  5.  3|              the everyday use of these treatments, because the study population
25   II,     5.  5.  3|        especially big for psychosocial treatments. Although there are indications
26   II,     5.  5.  3|                C (2002): Psychological treatments in schizophrenia: I. Meta-analysis
27   II,     5.  5.  3|                approach in relation to treatments, therapies and services,
28   II,     5.  5.  3|         comparison of immunomodulatory treatments and dose issues. All these
29   II,     5.  5.  3|             good practice review of MS treatments and therapies, reviewing
30   II,     5.  5.  3|               medications and surgical treatments currently available help
31   II,     5.  6.  4|               expensive and widespread treatments for rheumatoid arthritis
32   II,     5.  7.  1|              cost of renal replacement treatments are still in an expanding
33   II,     5.  7.  5|       Statistical Yearbook of Dialysis Treatments) is organized by the Czech
34   II,     5. 11.  3|             can be managed with simple treatments. In a study of 695 school
35   II,     5. 11.  7|                 Overview of studies of treatments for hand eczema – the EDEN
36   II,     6.  3.  3|           practices (tattooing, beauty treatments, etc.) are still important
37   II,     6.  4.  5|      antimicrobial agents, alternative treatments and vaccines; b) support
38   II,     7.  5    |            surveys), and other medical treatments (household surveys such
39   II,     8.  2.  1|     disadvantaged as dental or medical treatments may be withdrawn due to
40   II,     9.  1.  2|               Developments in surgical treatments and neonatal intensive care
41   II,     9.  1.  2|                towards developing drug treatments for genetic diseases. Full
42   II,     9.  1.  2|                development of non-drug treatments e.g. improved shunts for
43   II,     9.  3.  2|                can conceive, but these treatments increase multiple births –
44   II,     9.  4.  3|              focus on finding suitable treatments for this group or clarify
45   II,     9.  5.  3|      differences in access to specific treatments such as psychotherapy or
46   II,     9.  5.  3|                 and in the response to treatments and their outcomes. Female
47  III,    10.  2.  1|             medications and behavioral treatments for tobacco addiction (NID ~ ~
48  III,    10.  2.  1|                nicotine. The available treatments for nicotine addiction show
49  III,    10.  2.  1|           individuals exposed to these treatments, especially when delivered
50  III,    10.  2.  1|             the effectiveness of these treatments tends to be comparable regardless
51  III,    10.  2.  1|         analysis of clinical trials of treatments for alcohol use disorders.
52  III,    10.  2.  1|       treatment adds to other types of treatments including abstinence oriented
53  III,    10.  2.  1|         regarding the accessibility of treatments in some regions.~The description
54   IV,    11.  1.  5|              when particular tests and treatments should be used for specific
55   IV,    11.  1.  5|              rates or specific disease treatments (as for coronary heart disease
56   IV,    11.  1.  6|                diagnoses, severity and treatments. There is concern over how
57   IV,    11.  2.  2|       pharmaceutical and psycho-social treatments continues to grow, there
58   IV,    11.  3.  1|       increasing complexity of medical treatments (Simoens and Hurst, 2006)
59   IV,    11.  5.  4|            transplantation are medical treatments that require the full participation
60   IV,    12.  2    |           individuals exposed to these treatments, especially when delivered
61   IV,    12.  2    |             the effectiveness of these treatments tends to be comparable regardless
62   IV,    12. 10    |       financial support to infertility treatments.~ ~ ~ ~National Programme